no energy while taking semaglutide Woman shares journey of weight loss and gain after using 7 Reasons You're Not Losing

Were committed to ensuring that all patients have access to the medications they need, regardless of their insurance status

However, several key points matter for patients and clinicians: Hair loss has been reported with other GLP-1based weight loss drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro)

Diabetes is an established risk factor for NAION, so it is somewhat surprising that a similar trend was observed in the group without diabetes

Acknowledgment: The authors thank Katharine Phillips, MD, Weill Cornell Medical Center, for reviewing this piece and offering invaluable feedback

References [1] Helmstadter, J., et al

Semaglutide is a synthetic GLP-1 receptor agonist , a class of compounds that replicate the action of the bodys natural incretin hormones